Pfizer unites interventional coronary businesses:
This article was originally published in Clinica
US healthcare company Pfizer is uniting the interventional coronary businesses of its hospital products group into one entity - Schneider Worldwide. The unit will comprise the US and international Schneider organisations together with two recently acquired companies, Namic and Corvita. Heliane Canepa will be heading Schneider Worldwide, reporting to George Stewart, the president of the medical devices division of Pfizer's hospital products group.